Article
MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
Clinical and experimental rheumatology - 1 Jan 2000
Na So Young, Park Mi-Jin, Park Sun, Lee Eun-So
Abstract excerpt
OBJECTIVES: The goal of this study was to investigate whether microRNA-155 might be a potential therapeutic target for Behçet's disease (BD). METHODS: Expression levels of miR-155 were quantified using TaqMan microRNA assays in peripheral blood mononuclear cells and in isolated CD4+ T cells from BD patients and healthy controls. To identify targets of miR-155, luciferase reporter assays and western blotting were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
